385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

1479527018 Cutaneous AND/OR transdermal dosage form en Synonym Active Only initial character case insensitive SNOMED CT core module

2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cutaneous AND/OR transdermal dosage form	Is a	Type of drug preparation	false	Inferred relationship	Existential restriction modifier
Cutaneous AND/OR transdermal dosage form	Is a	Dose form by site prepared for	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nystatin 100,000units/g cream (Special Order)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.75% gel (Colorama Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Terbinafine 1% cream (Actavis UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 4% solution (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dermacort hydrocortisone 0.1% cream (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nizoral 2% shampoo (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 5% / Phenylephrine 0.5% nasal spray (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metronidazole 0.75% gel (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 0.05% solution (Special Order)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aluminium chloride 20% solution (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aluminium chloride 20% spray (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 0.5% solution (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 4% solution (J M McGill Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 2% shampoo (J M McGill Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% spray (J M McGill Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 2.5% / Prilocaine 2.5% cream (J M McGill Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Nicotine 7mg/24hours transdermal patches (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 4% solution (Colorama Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 2% shampoo (Colorama Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% spray (Colorama Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 2.5% / Prilocaine 2.5% cream (Colorama Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Emla 5% cream (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 5% medicated plasters (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Soya oil 84.75% bath oil (AM Distributions (Yorkshire) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Soya oil 82.95% / Lauromacrogols 15% bath oil (AM Distributions (Yorkshire) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Urea 10% cream (AM Distributions (Yorkshire) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches (A A H Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 2% shampoo (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 2.5% / Prilocaine 2.5% cream (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Chlorhexidine gluconate 4% solution (Niche Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Coal tar extract 2% shampoo (Niche Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 5% medicated plasters (Colorama Pharmaceuticals Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% spray (Niche Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Lidocaine 2.5% / Prilocaine 2.5% cream (Niche Pharma Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fenbid Forte 10% gel (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Isotrex 0.05% gel (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Allpresan diabetic foam cream Intensive	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Generic Allpresan diabetic foam cream Basic	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Allpresan diabetic foam cream Basic (Neuborg Pharma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Allpresan diabetic foam cream Intensive (Neuborg Pharma (UK) Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Potassium hydroxide 10% topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Potassium hydroxide 30% topical solution	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 1C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 2C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 3C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 6C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 7A (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 7C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 8A (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 8C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 9C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 10C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 11C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Covermark classic foundation 12C (Derma UK Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Metrogel 0.75% gel (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Potassium hydroxide 10% topical solution (Special Order)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Potassium hydroxide 30% topical solution (Special Order)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Estradiol 25micrograms/24hours transdermal patches (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Glyceryl trinitrate 10mg/24hours transdermal patches (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patches (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Glyceryl trinitrate 5mg/24hours transdermal patches (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% spray (Ennogen Healthcare Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Cocois ointment (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Versatis 5% medicated plasters (Waymade Healthcare Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aciclovir 5% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Calcipotriol 50micrograms/ml scalp solution (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clotrimazole 1% powder (Special Order)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 0.5% ointment (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 1% ointment (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Hydrocortisone 2.5% ointment (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ibuprofen 5% gel (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Dovobet gel Applicator (LEO Pharma)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mometasone 0.1% cream (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mometasone 0.1% ointment (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Mupirocin 2% ointment (Sigma Pharmaceuticals Plc)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Aciclovir 5% cream (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Amorolfine 5% medicated nail lacquer (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Yemex 25micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Yemex 50micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Yemex 75micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Yemex 100micrograms/hour transdermal patches (Sandoz Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Clobetasol 0.05% ointment (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 35micrograms/hour transdermal patches (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 52.5micrograms/hour transdermal patches (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Buprenorphine 70micrograms/hour transdermal patches (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Ketoconazole 2% shampoo (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier
Piroxicam 0.5% gel (DE Pharmaceuticals)	Has manufactured dose form	False	Cutaneous AND/OR transdermal dosage form	Inferred relationship	Existential restriction modifier

Start Previous Page 53 of 55 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1479527018	Cutaneous AND/OR transdermal dosage form	en	Synonym	Active	Only initial character case insensitive	SNOMED CT core module
2660179010	Cutaneous AND/OR transdermal dosage form (qualifier value)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT core module